201 related articles for article (PubMed ID: 38048423)
21. Circulating calprotectin levels four months after severe and non-severe COVID-19.
Abu Hussein N; Machahua C; Ruchti SC; Horn MP; Piquilloud L; Prella M; Geiser TK; von Garnier C; Funke-Chambour M
BMC Infect Dis; 2023 Oct; 23(1):650. PubMed ID: 37789266
[TBL] [Abstract][Full Text] [Related]
22. [The lung function status in patients with severe acute respiratory syndrome after ten years of convalescence in Tianjin].
Li L; Sun X; Wu Q; Wu Q; Xing Z; Yu H
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Aug; 38(8):575-8. PubMed ID: 26703338
[TBL] [Abstract][Full Text] [Related]
23. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer surgery after COVID-19 infection in a patient with severe interstitial pneumonia and restrictive ventilatory impairment.
Komatsu H; Izumi N; Tsukioka T; Inoue H; Ito R; Suzuki S; Nishiyama N
Surg Case Rep; 2022 Sep; 8(1):173. PubMed ID: 36129588
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.
Bazdyrev E; Panova M; Brachs M; Smolyarchuk E; Tsygankova D; Gofman L; Abdyusheva Y; Novikov F
J Transl Med; 2022 Nov; 20(1):506. PubMed ID: 36329513
[TBL] [Abstract][Full Text] [Related]
26. Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis.
Park EH; Hwang WC; Lee Y; Lee EY; Lee EB; Song YW; Park JK
Int J Rheum Dis; 2019 Mar; 22(3):507-515. PubMed ID: 30548402
[TBL] [Abstract][Full Text] [Related]
27. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase.
Huang Y; Tan C; Wu J; Chen M; Wang Z; Luo L; Zhou X; Liu X; Huang X; Yuan S; Chen C; Gao F; Huang J; Shan H; Liu J
Respir Res; 2020 Jun; 21(1):163. PubMed ID: 32600344
[TBL] [Abstract][Full Text] [Related]
28. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
[TBL] [Abstract][Full Text] [Related]
29. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
[TBL] [Abstract][Full Text] [Related]
30. Diffusing capacity and forced vital capacity in 5,003 asbestos-exposed workers: relationships to interstitial fibrosis (ILO profusion score) and pleural thickening.
Miller A; Warshaw R; Nezamis J
Am J Ind Med; 2013 Dec; 56(12):1383-93. PubMed ID: 24038345
[TBL] [Abstract][Full Text] [Related]
31. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes.
Frampton MW; Balmes JR; Bromberg PA; Stark P; Arjomandi M; Hazucha MJ; Rich DQ; Hollenbeck-Pringle D; Dagincourt N; Alexis N; Ganz P; Zareba W; Costantini MG
Res Rep Health Eff Inst; 2017 Jun; 2017(192, Pt 1):1-107. PubMed ID: 31898880
[TBL] [Abstract][Full Text] [Related]
32. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors.
di Filippo L; Compagnone N; Frara S; Allora A; Doga M; Rovere Querini P; Cremona G; Giustina A
Endocrine; 2022 Aug; 77(2):392-400. PubMed ID: 35676466
[TBL] [Abstract][Full Text] [Related]
33. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
34. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
35. Persistent
Matheson AM; McIntosh MJ; Kooner HK; Lee J; Desaigoudar V; Bier E; Driehuys B; Svenningsen S; Santyr GE; Kirby M; Albert MS; Shepelytskyi Y; Grynko V; Ouriadov A; Abdelrazek M; Dhaliwal I; Nicholson JM; Parraga G
Radiology; 2022 Nov; 305(2):466-476. PubMed ID: 35762891
[TBL] [Abstract][Full Text] [Related]
36. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
[TBL] [Abstract][Full Text] [Related]
37. Three to Six Months Evolution of Pulmonary Function and Radiological Features in Critical COVID-19 Patients: A Prospective Cohort.
Cabo-Gambin R; Benítez ID; Carmona P; Santiesteve S; Mínguez O; Vaca R; Moncusí-Moix A; Gort-Paniello C; García-Hidalgo MC; de Gonzalo-Calvo D; de Batlle J; Torres G; Torres A; Barbé F; González J;
Arch Bronconeumol; 2022 Apr; 58():59-62. PubMed ID: 34334879
[No Abstract] [Full Text] [Related]
38. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
Paterniti MO; Bi Y; Rekić D; Wang Y; Karimi-Shah BA; Chowdhury BA
Ann Am Thorac Soc; 2017 Sep; 14(9):1395-1402. PubMed ID: 28388260
[TBL] [Abstract][Full Text] [Related]
39. Early-life exposure to humidifier disinfectant determines the prognosis of lung function in children.
Cho HJ; Lee SY; Park D; Ryu SH; Yoon J; Jung S; Lee E; Yang SI; Hong SJ
BMC Pulm Med; 2019 Dec; 19(1):261. PubMed ID: 31870444
[TBL] [Abstract][Full Text] [Related]
40. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
